AL158147.2 | HCG2011465; Uncharacterized protein | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
TUSC5 | Tumor suppressor candidate 5 | Predicted membrane proteins
| ![](/images/50825/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50825/114809_B_7_7_rna_selected_60x60.jpg) | Tissue enriched |
ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/46467/ihc_cell_selected_60x60.jpg) | ![](/images/46467/104620_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
CIDEA | Cell death-inducing DFFA-like effector a | Disease related genes
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
MRAP | Melanocortin 2 receptor accessory protein | Disease related genes Predicted membrane proteins
| ![](/images/11024/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11093/65617_B_8_5_rna_selected_60x60.jpg) | Group enriched |
HEPN1 | Hepatocellular carcinoma, down-regulated 1 | | ![](/images/63054/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/63054/141043_B_7_4_rna_selected_60x60.jpg) | Group enriched |
DEFB132 | Defensin, beta 132 | Predicted secreted proteins
| ![](/images/46399/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/46399/ihc_cell_selected_60x60.jpg) | ![](/images/46399/102430_A_5_6_rna_selected_60x60.jpg) | Group enriched |
PLIN1 | Perilipin 1 | Disease related genes Plasma proteins Predicted membrane proteins
| | ![](/images/24299/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/33821/83355_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
PFKFB1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | Enzymes
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
AL109927.1 | HCG2032222; PRO2047; Uncharacterized protein | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
C14orf180 | Chromosome 14 open reading frame 180 | Predicted membrane proteins
| ![](/images/45001/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45001/98528_B_9_2_rna_selected_60x60.jpg) | Group enriched |
LIPE | Lipase, hormone-sensitive | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images/17700/ihc_cell_selected_60x60.jpg) | ![](/images/17700/132027_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
KCNIP2 | Kv channel interacting protein 2 | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
GYG2 | Glycogenin 2 | Enzymes
| ![](/images/64686/ihc_selected_60x60.jpg) | ![](/images/64686/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/64686/145594_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
FABP4 | Fatty acid binding protein 4, adipocyte | Cancer-related genes Plasma proteins
| | | | ![](/images/24961/54941_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
PRRT4 | Proline-rich transmembrane protein 4 | Predicted membrane proteins Predicted secreted proteins
| ![](/images/52681/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52681/130939_A_4_2_rna_selected_60x60.jpg) | Group enriched |
AQPEP | Aminopeptidase Q | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/53254/146500_B_8_2_rna_selected_60x60.jpg) | Group enriched |
TBX15 | T-box 15 | Disease related genes Transcription factors
| ![](/images/52245/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52245/128020_A_1_4_rna_selected_60x60.jpg) | Group enriched |
LEP | Leptin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images/30721/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/10490/ihc_cell_selected_60x60.jpg) | ![](/images/10490/32979_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
NAT8L | N-acetyltransferase 8-like (GCN5-related, putative) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| ![](/images/40677/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/40677/91345_B_9_3_rna_selected_60x60.jpg) | Group enriched |
CDH20 | Cadherin 20, type 2 | Predicted membrane proteins
| ![](/images/15490/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15490/35757_B_9_1_rna_selected_60x60.jpg) | Group enriched |
SCN4A | Sodium channel, voltage-gated, type IV, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/53992/ihc_selected_60x60.jpg) | ![](/images/53992/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/53992/121967_A_1_4_rna_selected_60x60.jpg) | Group enriched |
SLC25A18 | Solute carrier family 25 (glutamate carrier), member 18 | Mitochondrial proteins Plasma proteins Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
ALPK3 | Alpha-kinase 3 | Enzymes
| ![](/images/26558/ihc_selected_60x60.jpg) | ![](/images/26558/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/26558/54811_B_8_2_rna_selected_60x60.jpg) | Group enriched |
LPL | Lipoprotein lipase | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images/48749/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
PLIN4 | Perilipin 4 | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images/44682/ihc_cell_selected_60x60.jpg) | ![](/images/44682/152672_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
SLC7A10 | Solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 | Predicted membrane proteins Transporters
| ![](/images/41884/ihc_selected_60x60.jpg) | ![](/images/41884/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/41884/87774_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60902/141575_B_8_3_rna_selected_60x60.jpg) | Group enriched |
CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | Cancer-related genes Transcription factors
| ![](/images/65037/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/65037/150496_B_3_7_rna_selected_60x60.jpg) | Tissue enriched |
CIDEC | Cell death-inducing DFFA-like effector c | Disease related genes
| ![](/images/20553/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18837/42540_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
CSN1S1 | Casein alpha s1 | Cancer-related genes Predicted secreted proteins
| ![](/images/35659/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35659/73871_B_9_8_rna_selected_60x60.jpg) | Tissue enriched |
LGALS12 | Lectin, galactoside-binding, soluble, 12 | | ![](/images/12971/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/12971/29143_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
S100B | S100 calcium binding protein B | Cancer-related genes Candidate cardiovascular disease genes
| | | ![](/images/73/ihc_cell_selected_60x60.jpg) | ![](/images/73/1482_B_5_5_rna_selected_60x60.jpg) | Group enriched |
TIMP4 | TIMP metallopeptidase inhibitor 4 | Plasma proteins Predicted secreted proteins
| ![](/images/2771/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2771/6927_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
AC062017.1 | Uncharacterized protein | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
ACACB | Acetyl-CoA carboxylase beta | Enzymes Plasma proteins Predicted secreted proteins
| ![](/images/6554/ihc_selected_60x60.jpg) | ![](/images/6554/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/6554/17816_B_7_3_rna_selected_60x60.jpg) | Tissue enriched |
ACVR1C | Activin A receptor, type IC | Enzymes Predicted membrane proteins Predicted secreted proteins
| ![](/images/11933/ihc_selected_60x60.jpg) | ![](/images/7982/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/11933/28615_B_1_7_rna_selected_60x60.jpg) | Tissue enriched |
AL445665.1 | Protein LOC100996643 | | ![](/images/50052/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50052/143870_B_3_1_rna_selected_60x60.jpg) | Tissue enriched |
AOC2 | Amine oxidase, copper containing 2 (retina-specific) | Enzymes Predicted secreted proteins
| ![](/images/57779/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/57779/133414_B_8_2_rna_selected_60x60.jpg) | Group enriched |
C2CD4C | C2 calcium-dependent domain containing 4C | | ![](/images/55915/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/55915/ihc_cell_selected_60x60.jpg) | ![](/images/55915/128891_B_9_7_rna_selected_60x60.jpg) | Group enriched |
CDR1 | Cerebellar degeneration-related protein 1, 34kDa | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted membrane proteins
| | ![](/images/14044/if_selected_60x60.jpg) | ![](/images/14044/ihc_cell_selected_60x60.jpg) | ![](/images/3789/10114_B_2_1_rna_selected_60x60.jpg) | Group enriched |
DGAT2 | Diacylglycerol O-acyltransferase 2 | Enzymes Predicted membrane proteins
| ![](/images/13351/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13351/33391_B_8_5_rna_selected_60x60.jpg) | Group enriched |
PNPLA2 | Patatin-like phospholipase domain containing 2 | Disease related genes Enzymes Potential drug targets
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
PTGER3 | Prostaglandin E receptor 3 (subtype EP3) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/10689/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10689/151953_B_6_7_rna_selected_60x60.jpg) | Group enriched |
SAA1 | Serum amyloid A1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
SAA2 | Serum amyloid A2 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
SLC10A6 | Solute carrier family 10 (sodium/bile acid cotransporter), member 6 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/16662/ihc_cell_selected_60x60.jpg) | ![](/images/16662/37497_B_7_1_rna_selected_60x60.jpg) | Group enriched |
SLC29A4 | Solute carrier family 29 (equilibrative nucleoside transporter), member 4 | Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
SVEP1 | Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 | Predicted secreted proteins
| ![](/images/20610/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20610/47078_B_8_5_rna_selected_60x60.jpg) | Group enriched |